Guidance Sets Out How Notified Bodies Must Assess Highest Risk IVDs Under New Regulation
Executive Summary
The highest risk IVDs, which fall into class D, are subject to additional testing criteria. New guidance explains how the notified body acts − not only as reviewer but also as facilitator so additional safety and performance guarantees can be sought.
You may also be interested in...
Global Medtech Guidance Tracker: February 2022
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-six documents have been posted on the tracker since its last update.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.